Strategies  ||| S:0 E:11 ||| NNS
to  ||| S:11 E:14 ||| TO
prevent  ||| S:14 E:22 ||| VB
or  ||| S:22 E:25 ||| CC
reduce  ||| S:25 E:32 ||| VB
allergic  ||| S:32 E:41 ||| JJ
disease  ||| S:41 E:49 ||| NN
The  ||| S:49 E:53 ||| DT
need  ||| S:53 E:58 ||| NN
for  ||| S:58 E:62 ||| IN
allergy  ||| S:62 E:70 ||| JJ
prevention  ||| S:70 E:81 ||| NN
strategies  ||| S:81 E:92 ||| NNS
has  ||| S:92 E:96 ||| VBZ
never  ||| S:96 E:102 ||| RB
been  ||| S:102 E:107 ||| VBN
greater ||| S:107 E:114 ||| JJR
.  ||| S:114 E:116 ||| .
Surging  ||| S:116 E:124 ||| VBG
rates  ||| S:124 E:130 ||| NNS
of  ||| S:130 E:133 ||| IN
food  ||| S:133 E:138 ||| NN
allergy  ||| S:138 E:146 ||| NN
and  ||| S:146 E:150 ||| CC
eczema  ||| S:150 E:157 ||| NNS
are  ||| S:157 E:161 ||| VBP
now  ||| S:161 E:165 ||| RB
adding  ||| S:165 E:172 ||| VBG
to  ||| S:172 E:175 ||| TO
the  ||| S:175 E:179 ||| DT
already  ||| S:179 E:187 ||| RB
substantial  ||| S:187 E:199 ||| JJ
burden  ||| S:199 E:206 ||| NN
of  ||| S:206 E:209 ||| IN
asthma  ||| S:209 E:216 ||| NN
and  ||| S:216 E:220 ||| CC
respiratory  ||| S:220 E:232 ||| JJ
allergic  ||| S:232 E:241 ||| JJ
diseases ||| S:241 E:249 ||| NNS
.  ||| S:249 E:251 ||| .
The  ||| S:251 E:255 ||| DT
parallel  ||| S:255 E:264 ||| JJ
rise  ||| S:264 E:269 ||| NN
in  ||| S:269 E:272 ||| IN
many  ||| S:272 E:277 ||| JJ
other  ||| S:277 E:283 ||| JJ
immune  ||| S:283 E:290 ||| JJ
diseases  ||| S:290 E:299 ||| NNS
suggests  ||| S:299 E:308 ||| VBZ
that  ||| S:308 E:313 ||| IN
the  ||| S:313 E:317 ||| DT
developing  ||| S:317 E:328 ||| VBG
immune  ||| S:328 E:335 ||| JJ
system  ||| S:335 E:342 ||| NN
is  ||| S:342 E:345 ||| VBZ
highly  ||| S:345 E:352 ||| RB
vulnerable  ||| S:352 E:363 ||| JJ
to  ||| S:363 E:366 ||| TO
modern  ||| S:366 E:373 ||| JJ
environmental  ||| S:373 E:387 ||| JJ
changes ||| S:387 E:394 ||| NNS
.  ||| S:394 E:396 ||| .
These  ||| S:396 E:402 ||| DT
strong  ||| S:402 E:409 ||| JJ
environmental  ||| S:409 E:423 ||| JJ
pressures  ||| S:423 E:433 ||| NNS
may  ||| S:433 E:437 ||| MD
be  ||| S:437 E:440 ||| VB
one  ||| S:440 E:444 ||| CD
reason  ||| S:444 E:451 ||| NN
why  ||| S:451 E:455 ||| WRB
simple  ||| S:455 E:462 ||| JJ
allergen  ||| S:462 E:471 ||| JJ
avoidance  ||| S:471 E:481 ||| NN
strategies  ||| S:481 E:492 ||| NNS
have  ||| S:492 E:497 ||| VBP
not  ||| S:497 E:501 ||| RB
been  ||| S:501 E:506 ||| VBN
successful ||| S:506 E:516 ||| JJ
.  ||| S:516 E:518 ||| .
Another  ||| S:518 E:526 ||| DT
more  ||| S:526 E:531 ||| RBR
recent  ||| S:531 E:538 ||| JJ
strategy  ||| S:538 E:547 ||| NN
to  ||| S:547 E:550 ||| TO
curtail  ||| S:550 E:558 ||| VB
the  ||| S:558 E:562 ||| DT
allergy  ||| S:562 E:570 ||| JJ
epidemic  ||| S:570 E:579 ||| NN
has  ||| S:579 E:583 ||| VBZ
been  ||| S:583 E:588 ||| VBN
to  ||| S:588 E:591 ||| TO
identify  ||| S:591 E:600 ||| VB
factors  ||| S:600 E:608 ||| NNS
associated  ||| S:608 E:619 ||| VBN
with  ||| S:619 E:624 ||| IN
modern  ||| S:624 E:631 ||| JJ
lifestyle  ||| S:631 E:641 ||| NN
that  ||| S:641 E:646 ||| WDT
may  ||| S:646 E:650 ||| MD
be  ||| S:650 E:653 ||| VB
causally  ||| S:653 E:662 ||| VBN
linked  ||| S:662 E:669 ||| VBN
with  ||| S:669 E:674 ||| IN
allergic  ||| S:674 E:683 ||| JJ
disease ||| S:683 E:690 ||| NN
,  ||| S:690 E:692 ||| ,
in  ||| S:692 E:695 ||| IN
an  ||| S:695 E:698 ||| DT
attempt  ||| S:698 E:706 ||| NN
to  ||| S:706 E:709 ||| TO
restore  ||| S:709 E:717 ||| VB
more  ||| S:717 E:722 ||| RBR
favourable  ||| S:722 E:733 ||| JJ
conditions  ||| S:733 E:744 ||| NNS
for  ||| S:744 E:748 ||| IN
immune  ||| S:748 E:755 ||| JJ
tolerance  ||| S:755 E:765 ||| NN
during  ||| S:765 E:772 ||| IN
early  ||| S:772 E:778 ||| JJ
development ||| S:778 E:789 ||| NN
.  ||| S:789 E:791 ||| .
More  ||| S:791 E:796 ||| RBR
hygienic  ||| S:796 E:805 ||| JJ
conditions  ||| S:805 E:816 ||| NNS
and  ||| S:816 E:820 ||| CC
disruption  ||| S:820 E:831 ||| NN
of  ||| S:831 E:834 ||| IN
microbial  ||| S:834 E:844 ||| JJ
exposure  ||| S:844 E:853 ||| NN
have  ||| S:853 E:858 ||| VBP
prompted  ||| S:858 E:867 ||| VBN
strategies  ||| S:867 E:878 ||| NNS
to  ||| S:878 E:881 ||| TO
restore  ||| S:881 E:889 ||| VB
this  ||| S:889 E:894 ||| DT
balance  ||| S:894 E:902 ||| NN
using  ||| S:902 E:908 ||| VBG
probiotic  ||| S:908 E:918 ||| NNS
and  ||| S:918 E:922 ||| CC
prebiotic  ||| S:922 E:932 ||| JJ
supplements ||| S:932 E:943 ||| NN
.  ||| S:943 E:945 ||| .
Modern  ||| S:945 E:952 ||| JJ
dietary  ||| S:952 E:960 ||| JJ
changes  ||| S:960 E:968 ||| NNS
linked  ||| S:968 E:975 ||| VBN
with  ||| S:975 E:980 ||| IN
allergic  ||| S:980 E:989 ||| JJ
diseases  ||| S:989 E:998 ||| NNS
have  ||| S:998 E:1003 ||| VBP
prompted  ||| S:1003 E:1012 ||| VBN
supplementation  ||| S:1012 E:1028 ||| JJ
studies  ||| S:1028 E:1036 ||| NNS
to  ||| S:1036 E:1039 ||| TO
assess  ||| S:1039 E:1046 ||| VB
the  ||| S:1046 E:1050 ||| DT
preventive  ||| S:1050 E:1061 ||| JJ
merits  ||| S:1061 E:1068 ||| NNS
of  ||| S:1068 E:1071 ||| IN
specific  ||| S:1071 E:1080 ||| JJ
immunomodulatory  ||| S:1080 E:1097 ||| JJ
dietary  ||| S:1097 E:1105 ||| NNS
nutrients  ||| S:1105 E:1115 ||| VBP
such  ||| S:1115 E:1120 ||| JJ
as  ||| S:1120 E:1123 ||| IN
polyunsaturated  ||| S:1123 E:1139 ||| JJ
fatty  ||| S:1139 E:1145 ||| JJ
acids ||| S:1145 E:1150 ||| NNS
.  ||| S:1150 E:1152 ||| .
Other  ||| S:1152 E:1158 ||| JJ
nutrients  ||| S:1158 E:1168 ||| JJ
such  ||| S:1168 E:1173 ||| JJ
as  ||| S:1173 E:1176 ||| IN
antioxidants ||| S:1176 E:1188 ||| NN
,  ||| S:1188 E:1190 ||| ,
folate ||| S:1190 E:1196 ||| NN
,  ||| S:1196 E:1198 ||| ,
and  ||| S:1198 E:1202 ||| CC
vitamin  ||| S:1202 E:1210 ||| JJ
D  ||| S:1210 E:1212 ||| NNP
are  ||| S:1212 E:1216 ||| VBP
also  ||| S:1216 E:1221 ||| RB
currently  ||| S:1221 E:1231 ||| RB
under  ||| S:1231 E:1237 ||| IN
investigation ||| S:1237 E:1250 ||| NN
.  ||| S:1250 E:1252 ||| .
Modern  ||| S:1252 E:1259 ||| JJ
environmental  ||| S:1259 E:1273 ||| JJ
pollutants  ||| S:1273 E:1284 ||| NNS
have  ||| S:1284 E:1289 ||| VBP
also  ||| S:1289 E:1294 ||| RB
been  ||| S:1294 E:1299 ||| VBN
associated  ||| S:1299 E:1310 ||| VBN
with  ||| S:1310 E:1315 ||| IN
adverse  ||| S:1315 E:1323 ||| JJ
effects  ||| S:1323 E:1331 ||| NNS
on  ||| S:1331 E:1334 ||| IN
immune  ||| S:1334 E:1341 ||| JJ
development  ||| S:1341 E:1353 ||| NN
and  ||| S:1353 E:1357 ||| CC
the  ||| S:1357 E:1361 ||| DT
risk  ||| S:1361 E:1366 ||| NN
of  ||| S:1366 E:1369 ||| IN
disease ||| S:1369 E:1376 ||| NN
.  ||| S:1376 E:1378 ||| .
While  ||| S:1378 E:1384 ||| IN
many  ||| S:1384 E:1389 ||| JJ
of  ||| S:1389 E:1392 ||| IN
these  ||| S:1392 E:1398 ||| DT
avenues  ||| S:1398 E:1406 ||| NNS
have  ||| S:1406 E:1411 ||| VBP
provided  ||| S:1411 E:1420 ||| VBN
some  ||| S:1420 E:1425 ||| DT
promise ||| S:1425 E:1432 ||| NN
,  ||| S:1432 E:1434 ||| ,
they  ||| S:1434 E:1439 ||| PRP
have  ||| S:1439 E:1444 ||| VBP
not  ||| S:1444 E:1448 ||| RB
yet  ||| S:1448 E:1452 ||| RB
translated  ||| S:1452 E:1463 ||| VBN
into  ||| S:1463 E:1468 ||| IN
specific  ||| S:1468 E:1477 ||| JJ
recommendations ||| S:1477 E:1492 ||| NNS
.  ||| S:1492 E:1494 ||| .
Current  ||| S:1494 E:1502 ||| JJ
evidence-based  ||| S:1502 E:1517 ||| JJ
guidelines  ||| S:1517 E:1528 ||| NNS
for  ||| S:1528 E:1532 ||| IN
allergy  ||| S:1532 E:1540 ||| JJ
prevention  ||| S:1540 E:1551 ||| NNS
remain  ||| S:1551 E:1558 ||| VBP
limited  ||| S:1558 E:1566 ||| VBN
to  ||| S:1566 E:1569 ||| TO
avoidance  ||| S:1569 E:1579 ||| VB
of  ||| S:1579 E:1582 ||| IN
cigarette  ||| S:1582 E:1592 ||| NN
smoke ||| S:1592 E:1597 ||| NN
,  ||| S:1597 E:1599 ||| ,
promotion  ||| S:1599 E:1609 ||| NN
of  ||| S:1609 E:1612 ||| IN
breastfeeding  ||| S:1612 E:1626 ||| NN
and  ||| S:1626 E:1630 ||| CC
the  ||| S:1630 E:1634 ||| DT
use  ||| S:1634 E:1638 ||| NN
of  ||| S:1638 E:1641 ||| IN
hydrolysed  ||| S:1641 E:1652 ||| JJ
formula  ||| S:1652 E:1660 ||| NN
when  ||| S:1660 E:1665 ||| WRB
breastfeeding  ||| S:1665 E:1679 ||| NN
is  ||| S:1679 E:1682 ||| VBZ
not  ||| S:1682 E:1686 ||| RB
possible ||| S:1686 E:1694 ||| JJ
.  ||| S:1694 E:1696 ||| .
Allergen  ||| S:1696 E:1705 ||| JJ
avoidance  ||| S:1705 E:1715 ||| NN
strategies  ||| S:1715 E:1726 ||| NNS
have  ||| S:1726 E:1731 ||| VBP
been  ||| S:1731 E:1736 ||| VBN
largely  ||| S:1736 E:1744 ||| RB
removed  ||| S:1744 E:1752 ||| VBN
from  ||| S:1752 E:1757 ||| IN
most  ||| S:1757 E:1762 ||| JJS
guidelines ||| S:1762 E:1772 ||| NNS
.  ||| S:1772 E:1774 ||| .
It  ||| S:1774 E:1777 ||| PRP
is  ||| S:1777 E:1780 ||| VBZ
hoped  ||| S:1780 E:1786 ||| VBN
that  ||| S:1786 E:1791 ||| IN
a  ||| S:1791 E:1793 ||| DT
number  ||| S:1793 E:1800 ||| NN
of  ||| S:1800 E:1803 ||| IN
ongoing  ||| S:1803 E:1811 ||| JJ
studies  ||| S:1811 E:1819 ||| NNS
will  ||| S:1819 E:1824 ||| MD
help  ||| S:1824 E:1829 ||| VB
provide  ||| S:1829 E:1837 ||| VB
clearer  ||| S:1837 E:1845 ||| JJR
recommendations  ||| S:1845 E:1861 ||| NNS
around  ||| S:1861 E:1868 ||| IN
the  ||| S:1868 E:1872 ||| DT
use  ||| S:1872 E:1876 ||| NN
of  ||| S:1876 E:1879 ||| IN
probiotics ||| S:1879 E:1889 ||| NN
,  ||| S:1889 E:1891 ||| ,
prebiotics ||| S:1891 E:1901 ||| NN
,  ||| S:1901 E:1903 ||| ,
specific  ||| S:1903 E:1912 ||| JJ
dietary  ||| S:1912 E:1920 ||| JJ
nutrients  ||| S:1920 E:1930 ||| NN
and  ||| S:1930 E:1934 ||| CC
the  ||| S:1934 E:1938 ||| DT
role  ||| S:1938 E:1943 ||| NN
of  ||| S:1943 E:1946 ||| IN
early  ||| S:1946 E:1952 ||| JJ
introduction  ||| S:1952 E:1965 ||| NN
of  ||| S:1965 E:1968 ||| IN
allergenic  ||| S:1968 E:1979 ||| JJ
foods  ||| S:1979 E:1985 ||| NNS
for  ||| S:1985 E:1989 ||| IN
the  ||| S:1989 E:1993 ||| DT
promotion  ||| S:1993 E:2003 ||| NN
of  ||| S:2003 E:2006 ||| IN
tolerance ||| S:2006 E:2015 ||| NN
.  ||| S:2015 E:2017 ||| .
Despite  ||| S:2017 E:2025 ||| IN
the  ||| S:2025 E:2029 ||| DT
current  ||| S:2029 E:2037 ||| JJ
uncertainties ||| S:2037 E:2050 ||| NNS
,  ||| S:2050 E:2052 ||| ,
prevention  ||| S:2052 E:2063 ||| NN
remains  ||| S:2063 E:2071 ||| VBZ
the  ||| S:2071 E:2075 ||| DT
best  ||| S:2075 E:2080 ||| RBS
long-term  ||| S:2080 E:2090 ||| JJ
strategy  ||| S:2090 E:2099 ||| NN
to  ||| S:2099 E:2102 ||| TO
reduce  ||| S:2102 E:2109 ||| VB
the  ||| S:2109 E:2113 ||| DT
growing  ||| S:2113 E:2121 ||| VBG
burden  ||| S:2121 E:2128 ||| NN
of  ||| S:2128 E:2131 ||| IN
allergic  ||| S:2131 E:2140 ||| JJ
disease ||| S:2140 E:2147 ||| NN
.  ||| S:2147 E:2149 ||| .
